scholarly journals Pharmacologic Activation of the G Protein–Coupled Estrogen Receptor Inhibits Pancreatic Ductal Adenocarcinoma

2020 ◽  
Vol 10 (4) ◽  
pp. 868-880.e1 ◽  
Author(s):  
Christopher A. Natale ◽  
Jinyang Li ◽  
Jason R. Pitarresi ◽  
Robert J. Norgard ◽  
Tzvete Dentchev ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Pancreatic Ductal Adenocarcinoma ◽  
G Protein ◽  
Ductal Adenocarcinoma ◽  
G Protein Coupled

scholarly journals Pharmacologic activation of the G protein-coupled estrogen receptor inhibits pancreatic ductal adenocarcinoma

2018 ◽  
Author(s):  
Christopher A. Natale ◽  
Jinyang Li ◽  
Tzvete Dentchev ◽  
Brian C. Capell ◽  
John T. Seykora ◽  
...  
Keyword(s):  
Estrogen Receptor ◽  
Pancreatic Ductal Adenocarcinoma ◽  
G Protein ◽  
Immune Therapy ◽  
Estrogen Signaling ◽  
Ductal Adenocarcinoma ◽  
Programmed Death Ligand 1 ◽  
Programmed Death ◽  
Cancer Types ◽  
G Protein Coupled

AbstractFemale sex is associated with lower incidence and improved clinical outcomes for many cancer types, including pancreatic ductal adenocarcinoma (PDAC). Although the mechanisms responsible for this sex difference are unknown, recent data suggests nonclassical estrogen signaling through the G Protein-coupled Estrogen Receptor (GPER) is likely involved. Here we used murine syngeneic tumor models and human xenografts to test whether GPER signaling inhibits pancreatic ductal adenocarcinoma (PDAC). Activation of GPER with the specific, small molecule agonist G-1 inhibited PDAC proliferation, depleted c-Myc and programmed death ligand 1 (PD-L1), and increased tumor cell immunogenicity. Systemically delivered G-1 was well tolerated in PDAC bearing mice, significantly prolonged survival, and markedly increased the efficacy of PD-1 targeted immune therapy. We detected GPER protein in a majority of spontaneous human PDAC tumors. These data, coupled with the wide tissue distribution of GPER, and our previous work showing that G-1 inhibits melanoma, suggest that GPER agonists may be useful against many different cancer types.

Sign in / Sign up

Export Citation Format

Share Document